EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--Mar 31, 2026--
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis ®, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber ®, the latest addition to the DBX ® family.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331524927/en/
For decades, DBX has been a trusted name in demineralized bone matrix, earning its reputation through proven performance in operating rooms around the world. DBX Fiber expands the DBX portfolio with a fiber tissue form processed to provide surgeons with superior handling and osteoinductive potential when addressing complex anatomy and challenging fusion environments.
“DBX has long been recognized for its reliable performance and proven processing methods,” said Brad Bailey, Vice President and General Manager of MTF Biologics’ Orthopedic Franchise. “We’re proud to expand the DBX family and strengthen our partnership with Kolosis by bringing surgeons another option within a tissue portfolio line they know and trust.”
Through its partnership with MTF Biologics, Kolosis continues to expand access to innovative biologic technologies for surgeons across spine and orthopedic procedures. The addition of DBX Fiber enhances Kolosis’ best-in-class portfolio of surgical biologics, which already includes DBX Mix ® and DBX Putty ®, as well as technologies such as Kore Fiber ®, a 100% cortical bone allograft, and Summit Matrix ™, an advanced synthetic bone graft manufactured to support bone regeneration in orthopedic and spinal procedures.
“Kolosis continues to strengthen its position as the leading pure-play orthobiologics provider in spine and orthopedics, and the addition of DBX Fiber is another important step in expanding our portfolio,” said Collin Begley, CEO of Kolosis. “Through our partnership with MTF Biologics, we’re able to expand the DBX family with a fiber format that offers surgeons greater versatility while continuing to deliver the trusted biologics solutions they rely on.”
About MTF Biologics
MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. In partnership with organ and tissue recovery organizations, MTF Biologics provides exceptional services, resources, and expertise to donors and their families; tissue and organ transplant patients; and clinicians and scientists who advance patient care.
The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized screening, coordination, and communications services to organ transplant centers, organ, tissue, and eye procurement organizations, and the hospitals and patients that they serve. Its sister organization, Deutsches Institut für Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. For more information, please visit www.mtfbiologics.org.
About Kolosis BIO
Kolosis BIO is a rising biologics pure-play, dedicated to commercializing cutting-edge technologies to multiple verticals in the surgical biologics space. With a proven track record of scaling market-leading technologies, Kolosis is dedicated to driving innovation and pushing the boundaries of science to enhance patient outcomes. With a focus on providing bold technologies and relentless execution, Kolosis has become a leading force in the surgical biologics market. For more information, please visit www.kolosis.com.
MTF Biologics and Kolosis BIO Launch the Latest Addition to the DBX Family: DBX Fiber
NEW YORK (AP) — Spice and flavorings company McCormick announced on Tuesday that it’s combining with Unilever’s foods division, which includes brands like Hellmann’s and Knorr.
The merger is the latest in a string of actions in the packaged food sector, as companies contend with inflation and changing consumer tastes. Last year, both Keurig Dr Pepper and Kraft Heinz announced plans to unwind huge mergers, although Kraft later put that plan on hold. Mars recently bought Cheez-It maker Kellanova while Nutella maker Ferrero bought WK Kellogg.
The combined company will maintain McCormick’s name and leadership. But upon closing, Unilever and its shareholders are expected to own 65% of the food company's outstanding equity, amounting $29.1 billion. Unilever would also get $15.7 billion in cash. Meanwhile, McCormick shareholders will own 35.0%.
McCormick and its red-capped array of spices is a $15 billion company and the stable of brands it’s adding from Unilever are worth billions more. The companies said on Tuesday that McCormick and Unilever would have a combined revenue of $20 billion for the 2025 fiscal year.
McCormick said the deal will give it better access to high-growth regions like Latin America and Asia, where Unilever has an extensive presence. It will also expand Unilever's footprint in North America, where McCormick has a stronger profile.
The companies expect to grow their presence in food service. Unilever has traditionally been a stronger player in restaurant kitchens, while McCormick's products are often found more in the dining room, on tables.
The combined companies said they expect to generate $600 million in annual cost savings.
“Together, we will be better positioned to accelerate growth in attractive categories,” McCormick CEO Brendan Foley said in a prepared statement.
The transaction is expected to close by mid-2027, the companies said Tuesday, pending both shareholder and regulatory approval. The deal excludes Unilever’s food business in India, Nepal and Portugal.
Unilever, which is based in London, was founded nearly a century ago when Dutch margarine maker Margarine Unie merged with British soap maker Lever Brothers. The conglomerate now makes dozens of different brands, including Dove soap, Vaseline, Hellmann’s mayonnaise, Liquid I.V. hydration, Axe body spray and Pepsodent toothpaste.
In recent years, Unilever has been shifting away from food in favor of beauty and wellness categories, where it sees more potential for growth.
“For Unilever, this transaction is another decisive step in sharpening our portfolio and accelerating our strategy towards high-growth categories,” Unilever CEO Fernando Fernández said in a statement.
In 2024, Unilever announced it was spinning off its ice cream business, which included the Ben & Jerry’s, Magnum and Breyers brands. That business became the Magnum Ice Cream Co., which is based in Amsterdam. Last year, Unilever sold The Vegetarian Butcher, a plant-based meat brand, and Graze, a healthy snacking brand.
Unilever's food sales, which make up one-quarter of its total sales, fell by 3% last year. Many packaged food companies have been hurt in recent years as consumers shift to cheaper store brands or less processed foods.
McCormick, based in Hunt Valley, Maryland, has been expanding its portfolio to take advantage of consumers’ growing interest in global flavors and sauces. The 137-year-old company bought Reckitt Benckiser’s food division — including the French’s mustard and Frank’s RedHot sauce brands — in 2017. In 2020, it bought Cholula, a Mexican hot sauce brand.
Foley said spices and flavors have remained resilient, transcending age, culture, dietary preferences and income levels. McCormick's net sales grew 2% last year.
“Flavor is fully aligned with today’s health and wellness priorities, as consumers increasingly focus on cooking at home, adding more protein and produce and pursuing healthier lifestyles,” Foley said Tuesday during a conference call with investors.
Unilever shares fell 6% Tuesday afternoon while McCormick's shares slid 5%.
Max Gumport, a senior analyst for BNP Paribas Equity Research, said in a note to investors that McCormick has a strong track record with previous acquisitions. But he said investors are likely concerned about the complexity of the merger and the high number of recent deals in the food industry.
Durbin reported from Detroit.
FILE - This Tuesday Nov. 24, 2020 photo shows the logo for McCormick & Co. AP Photo/Donald King, File)
